Abstract Details
|
Pierre Durozard
(APHM)
PRESENTER |
No disclosure on file |
| Adil Maarouf | Adil Maarouf has nothing to disclose. |
| No disclosure on file | |
| Aurelie Ruet (Hopital Pellegrin) | The institution of Aurelie Ruet has received research support from BIOGEN. The institution of Aurelie Ruet has received research support from ROCHE. The institution of Aurelie Ruet has received research support from SANOFI GENZYME. The institution of Aurelie Ruet has received research support from BMS. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Horizon therapeutic. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Board member with Alexion. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with BIOGEN. Aurelie Ruet has received personal compensation in the range of $500-$4,999 for serving as a Speaker meeting with MERCK. Aurelie Ruet has received personal compensation in the range of $0-$499 for serving as a Speaker meeting with Sanofi Genzyme. |
| Bruno Brochet, MD, FEAN (University of Bordeaux) | Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene. |
| Sandra Vukusic, MD (Hopital Neurologique Pierre Wertheimer) | The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Vukusic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. |
| Clarisse Carra-Dalliere | No disclosure on file |
| Pierre Labauge, MD | Dr. Labauge has nothing to disclose. |
| Guillaume Mathey | Guillaume Mathey has nothing to disclose. |
| Marc Debouverie, MD (Hospital Central) | Dr. Debouverie has nothing to disclose. |
| Caroline Papeix (GH Pitie Salpetriere) | Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Caroline Papeix has received personal compensation in the range of $0-$499 for serving as a Consultant for NOVARTIS . |
| Elisabeth Maillart | No disclosure on file |
| Catherine Lubetzki (Hopital De La Salpetriere) | Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND. |
| Caroline Bensa | Caroline Bensa has nothing to disclose. |
| Olivier F. Gout, MD (Hôpital Fondation A de Rothschild) | Dr. Gout has nothing to disclose. |
| Claire Giannesini | No disclosure on file |
| Bruno Stankoff (Hopital De La Pitie Salpetriere) | Bruno Stankoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Teva, Novartis, Biogen. The institution of Bruno Stankoff has received research support from Roche, Sanofi, Serono . |
| David Brassat, MD, PhD (Roche) | No disclosure on file |
| Audrey Rico Lamy (Hopital Timone Adultes) | No disclosure on file |
| Jean Pelletier, MD, PhD (Dpt of Neurology, CHU Timone) | Dr. Pelletier has nothing to disclose. |
| Bertrand Audoin | No disclosure on file |